Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China flag China · Delayed Price · Currency is CNY
23.51
-1.06 (-4.31%)
Nov 13, 2026, 3:04 PM CST

SHE:002940 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,2701,4251,5381,6211,5681,380
Revenue Growth
-13.71%-7.35%-5.10%3.32%13.62%7.03%
Gross Profit
486.13557.6612.57706.85893.58892.36
Operating Income
128.52152.19118.37163.64141.77151.25
Net Income
110.36125.4480.33138.37127.3119.84
Earnings Per Share
0.540.620.400.690.640.60
EPS Growth
0.13%55.00%-42.03%7.81%6.67%-30.30%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Preparations
677.86546.98649.61933.28973.9
Raw Materials
575.86747.44806.92607.17389.69
Specialty Intermediates
139.94200.1149.68--
Others
31.1443.365.358.095.48
Total
1,4251,5381,6261,5681,380

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
810.56789.67733.42869.75804.76748.51
Total Debt
426.11454.42487.08589.52346.961.76
Net Cash (Debt)
384.45335.25246.34280.23457.8746.75
Net Cash Growth
19.71%36.09%-12.10%-38.79%-38.69%-11.34%
Net Cash Per Share
1.881.661.231.402.303.74

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
219.51244.13253.6276.91184.75197.65
Capital Expenditures
-58.35-49.94-94.46-124.95-68.82-87.32
Free Cash Flow
161.16194.19159.14151.96115.92110.33
Free Cash Flow Growth
11.19%22.02%4.72%31.09%5.07%2.49%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
38.29%39.13%39.83%43.62%56.97%64.65%
Operating Margin
10.12%10.68%7.70%10.10%9.04%10.96%
Pretax Margin
11.47%12.65%10.30%12.79%9.37%12.51%
Profit Margin
8.69%8.80%5.22%8.54%8.12%8.68%
FCF Margin
12.69%13.63%10.35%9.38%7.39%7.99%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.2500.2500.1250.2100.2070.143
Dividend Per Share Growth
100.00%100.00%-40.48%1.50%44.99%-39.99%
Dividend Yield
1.06%0.75%0.94%0.96%1.11%0.81%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
43.5452.4032.7731.6328.9429.09
P/FCF Ratio
29.9033.8516.5428.8031.7831.59
PS Ratio
3.794.611.712.702.352.53